Ascendis Pharma AS - K08588103
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | History | New | 6,162,042 | 1,409,444 | 0.97% | — | 1 | +6,162,042 | New | Q1 2026 | May 15, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | History | New | 1,530,345 | 350,036 | 0.04% | — | 2 | +1,530,345 | New | Q1 2026 | May 15, 2026 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | History | New | 127,562 | 29,177 | 0.21% | — | 3 | +127,562 | New | Q1 2026 | May 15, 2026 |
| TUDOR INVESTMENT CORP ET AL | History | New | 38,600 | 8,828 | 0.02% | — | 4 | +38,600 | New | Q1 2026 | May 15, 2026 |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | History | New | 5,784 | 1,322 | 0.0% | — | 5 | +5,784 | New | Q1 2026 | May 14, 2026 |
| Legato Capital Management LLC | History | New | 1,748 | 399 | 0.04% | — | 6 | +1,748 | New | Q1 2026 | May 14, 2026 |
| SBI Securities Co., Ltd. | History | New | 3 | 0 | — | — | — | +3 | New | Q1 2026 | Apr 27, 2026 |